Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Compound trial record
Compound · clinical trials

Pethidine clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 3 trials in our Italy, Singapore and Israel registers that name Pethidine as an intervention. Synced 11 Nov 2026
3Current trials
1Recruiting now
3Lead sponsors
3Country registers
At a glance

Pethidine is named as an intervention in 3 current clinical trials in our Italy, Singapore and Israel registers. 1 is recruiting patients now. The most common phase is Phase 4. The sponsor with the most trials is Fondazione Andrea Cesalpino Arezzo ONLUS (1). The most-studied condition is Sedation During Bronchoscopy.

What health systems spend on Pethidine

All medicines →
ENNHS England
£93k
1,663 items dispensed, Sep 2025 to Aug 2026
+8% on the previous 12 months
Net ingredient cost, community prescriptions
USUS Medicaid
No single-ingredient product reimbursed by Medicaid in 2025
Amount Medicaid reimbursed, before rebates

From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.

Patient leaflets for Pethidine

The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.

  • IE
    Ireland: 1 product on the HPRA list
    Each product record links to the HPRA, which publishes the leaflet and SmPC.
  • UK
    United Kingdom: Search MHRA Products
    Patient information leaflets and SmPCs for UK-licensed products.
  • US
    United States: Search DailyMed
    FDA-approved labels, including patient and medication guides.

Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.

Trials by status

  • Recruiting133%
  • Not yet open133%
  • Active, closed133%

Trials by phase

  • Phase 4133%
  • Phase 2/3133%
  • Not applicable133%
01

Clinical trials of Pethidine

3 trials
StudyPhaseStatusLead sponsorRegisters
Combined Intravenous Tramadol and Paracetamol Versus Intramuscular Pethidine for Pain Relief During the First Stage of Labor. Compare the Efficacy and Adverse Effects
NCT07264309 · ClinicalTrials.gov ↗ · Pain Management, Birth
Not applicable Recruiting Zohar Nachum Israel
Balanced Analgosedation in Bronchoscopy: Propofol/Pethidine Versus Midazolam/Pethidine
NCT06736938 · ClinicalTrials.gov ↗ · Sedation During Bronchoscopy
Phase 4 Not yet open Fondazione Andrea Cesalpino Arezzo ONLUS Italy
CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)
NCT03167905 · ClinicalTrials.gov ↗ · Depression, Postpartum, Analgesia, Obstetrical, Anesthesia, Obstetrical
Phase 2/3 Active, closed KK Women's and Children's Hospital Singapore

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Pethidine across our data

Ireland · EU · US

The same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.

Licensed in Ireland (HPRA)

1 single-substance product containing Pethidine on the HPRA medicines list.

All 1 Irish product →

Supply shortages

No entry for Pethidine in the EMA, FDA or German BfArM shortage lists we track.

03

Conditions studied with Pethidine

6 conditions
Sedation During Bronchoscopy1Depression, Postpartum1Analgesia, Obstetrical1Anesthesia, Obstetrical1Pain Management1Birth1
04

Sponsors

lead sponsor per trial
Lead sponsorTrials
Fondazione Andrea Cesalpino Arezzo ONLUS1
KK Women's and Children's Hospital1
Zohar Nachum1
05

By country register

RegisterTrialsRecruiting
Clinical trials in Italy10
Clinical trials in Singapore10
Clinical trials in Israel11

A trial with sites in more than one country appears in each of those registers.

06

Related compounds

07

Questions about Pethidine trials

How many clinical trials are testing Pethidine?

3 current trials in our Italy, Singapore and Israel registers name Pethidine as a drug or biological intervention, as of the registry sync on 11 November 2026. Completed and withdrawn studies are not counted.

Are Pethidine trials recruiting patients?

Yes. 1 of the 3 trials is recruiting: 1 with sites in Israel. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Who sponsors Pethidine clinical trials?

Fondazione Andrea Cesalpino Arezzo ONLUS (1), KK Women's and Children's Hospital (1) and Zohar Nachum (1). The number in brackets is how many trials each organisation leads.

Is Pethidine licensed in Ireland?

Yes. The HPRA medicines list includes 1 single-substance product containing Pethidine, for example Pethidine Hydrochloride 50mg/ml Solution for Injection (Mercury Pharmaceuticals (Ireland) Ltd). A licence does not mean a product is currently marketed or reimbursed; see each product's record.

Is there a Pethidine shortage?

Not in the lists we track: Pethidine has no entry in the EMA, FDA or German BfArM shortage registers as of their latest sync.

Where does this information come from?

Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Pethidine works or whether it is effective, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Pethidine works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Pethidine (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 11 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.